Virtus Biotech Clinical Trials ETF BBC
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.65%
- Net assets
- $46.4M
- Holdings
- 132
- 12-month distribution yield
- 1.52%
- Asset class
- Equity
Virtus Biotech Clinical Trials ETF (BBC) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Virtus. Its category is Equity · Global (equity). Its last price was US$42.96 on 20 Oct 2026. Its expense ratio is 0.65% a year, from its prospectus dated 27 Feb 2026. It reported net assets of US$46.39 million as of 31 Jul 2026. Its latest holdings report lists 132 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.66 a unit, a 12-month distribution yield of 1.52%, paid yearly.
Fees
- Total annual operating expenses (gross)
- 0.65%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.65%
- Prospectus date
- 27 Feb 2026
- Filed with the SEC
- 27 Feb 2026
Size and reporting
- Net assets
- $46,392,581
- Total assets
- $48,033,383
- Holdings as of
- 31 Jul 2026
- Report made public
- 29 Sep 2026 (60 days after the month end)
Top holdings
Largest 25 of 132 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | No identifier reported | 3.48% | $1.6M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | FIRST TRACKS BIOTHERAPEUTICS INC FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | US3371851029 | 1.67% | $776K | Equity (common) | United States | USD |
| 3 | MBX BIOSCIENCES INC MBX BIOSCIENCES INC COM | US55287L1017 | 1.24% | $577K | Equity (common) | United States | USD |
| 4 | ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | US04650F1012 | 1.23% | $569K | Equity (common) | United States | USD |
| 5 | MONOPAR THERAPEUTICS INC MONOPAR THERAPEUTICS INC COM NEW | US61023L2079 | 1.21% | $563K | Equity (common) | United States | USD |
| 6 | DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC COM SHS | CA24477V1058 | 1.18% | $547K | Equity (common) | Canada | USD |
| 7 | XENCOR INC XENCOR INC COM | US98401F1057 | 1.10% | $509K | Equity (common) | United States | USD |
| 8 | ZENAS BIOPHARMA INC ZENAS BIOPHARMA INC COM | US98937L1052 | 1.06% | $494K | Equity (common) | United States | USD |
| 9 | UNIQURE NV UNIQURE NV SHS | NL0010696654 | 1.06% | $492K | Equity (common) | Netherlands | USD |
| 10 | APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC COM | US03770N1019 | 1.02% | $472K | Equity (common) | United States | USD |
| 11 | VOR BIOPHARMA INC VOR BIOPHARMA INC COM NEW | US9290332074 | 0.99% | $458K | Equity (common) | United States | USD |
| 12 | REGENXBIO INC REGENXBIO INC COM | US75901B1070 | 0.97% | $452K | Equity (common) | United States | USD |
| 13 | LB PHARMACEUTICALS INC LB PHARMACEUTICALS INC COM SHS | US50180M1080 | 0.94% | $438K | Equity (common) | United States | USD |
| 14 | DAMORA THERAPEUTICS INC DAMORA THERAPEUTICS INC COM USD0.00001 | KYG2646Y1044 | 0.93% | $434K | Equity (common) | Cayman Islands | USD |
| 15 | AMYLYX PHARMACEUTICALS INC AMYLYX PHARMACEUTICALS INC COM | US03237H1014 | 0.93% | $433K | Equity (common) | United States | USD |
| 16 | DYNE THERAPEUTICS INC DYNE THERAPEUTICS INC COM | US26818M1080 | 0.93% | $430K | Equity (common) | United States | USD |
| 17 | ORUKA THERAPEUTICS INC ORUKA THERAPEUTICS INC COM | US6876041087 | 0.93% | $429K | Equity (common) | United States | USD |
| 18 | NURIX THERAPEUTICS INC NURIX THERAPEUTICS INC COM | US67080M1036 | 0.92% | $426K | Equity (common) | United States | USD |
| 19 | ORIC PHARMACEUTICALS INC ORIC PHARMACEUTICALS INC COM | US68622P1093 | 0.90% | $416K | Equity (common) | United States | USD |
| 20 | GH RESEARCH PLC GH RESEARCH PLC ORDINARY SHARES | IE000GID8VI0 | 0.89% | $413K | Equity (common) | Ireland | USD |
| 21 | SIONNA THERAPEUTICS INC SIONNA THERAPEUTICS INC COM | US8294011080 | 0.88% | $408K | Equity (common) | United States | USD |
| 22 | DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC COM | US2528281080 | 0.87% | $405K | Equity (common) | United States | USD |
| 23 | ERASCA INC ERASCA INC COM | US29479A1088 | 0.87% | $402K | Equity (common) | United States | USD |
| 24 | JADE BIOSCIENCES INC JADE BIOSCIENCES INC COM NEW | US0080642061 | 0.86% | $400K | Equity (common) | United States | USD |
| 25 | SELLAS LIFE SCIENCES GROUP INC SELLAS LIFE SCIENCES GROUP INC COM NEW | US81642T2096 | 0.86% | $397K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.84% | |
| Short-term investment vehicles (cash funds) | 3.48% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 86.66% | |
| Cayman Islands | 5.32% | |
| Canada | 3.40% | |
| Netherlands | 3.00% | |
| Ireland | 1.55% | |
| United Kingdom | 1.27% | |
| British Virgin Islands | 0.80% | |
| Switzerland | 0.68% | |
| Singapore | 0.63% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 103.32% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 8.11% | |
| Health Technology | 1.02% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.6550
- 12-month yield
- 1.52%
- Frequency
- Yearly
- Latest ex-date
- 22 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.6550) ÷ latest price ($42.96) × 100 = 1.52%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (3 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Dec 2025 | $0.6550 |
| 20 Dec 2024 | $0.2400 |
| 20 Dec 2023 | $0.0820 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000047353) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- BBC and VT Vanguard Total World Stock Index ETF
- BBC and SMH VanEck Semiconductor ETF
- BBC and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- BBC and CGDV Capital Group Dividend Value ETF